Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Versus Placebo in Addition to Paclitaxel and Carboplatin

ClinicalTrials.gov ID: NCT01285609

Public ClinicalTrials.gov record NCT01285609. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 4:46 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Multicenter, Double-Blind, Phase 3 Trial Comparing the Efficacy of Ipilimumab in Addition to Paclitaxel and Carboplatin Versus Placebo in Addition to Paclitaxel and Carboplatin in Subjects With Stage IV/Recurrent Non Small Cell Lung Cancer (NSCLC)

Study identification

NCT ID
NCT01285609
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
1,289 participants

Conditions and interventions

Interventions

  • Ipilimumab Drug
  • Placebo Drug
  • Paclitaxel Drug
  • Carboplatin Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 15, 2011
Primary completion
Jun 8, 2015
Completion
Aug 21, 2017
Last update posted
Jun 17, 2020

2011 – 2017

United States locations

U.S. sites
33
U.S. states
20
U.S. cities
32
Facility City State ZIP Site status
Sharp Memorial Hospital San Diego California 92123
Va Connecticut Healthcare System West Haven Connecticut 06516
Lynn Cancer Institute Center For Hematology-Oncology Boca Raton Florida 33486
Integrated Community Oncology Network Jacksonville Florida 32256
University Of Illinois At Chicago Medical Center Chicago Illinois 60612
Quincy Medical Group Quincy Illinois 62301
Presence Medical Group Hematology Oncology Skokie Illinois 60076
Southern Illinois University School Of Medicine Springfield Illinois 62794-9678
St. Francis Hospital & Health Centers Indianapolis Indiana 46237
Floyd Memorial Cancer Center Of Indiana New Albany Indiana 47150
Kentucky Cancer Clinic Hazard Kentucky 41701
Norton Cancer Institute Louisville Kentucky 40207
Montgomery Cancer Center Mount Sterling Kentucky 40353
St Joseph Mercy Hospital Ypsilanti Michigan 48197
University Of Kansas Cancer Center Kansas City Missouri 64131
Washington University School Of Medicine St Louis Missouri 63110
Dartmouth-Hitchcock Medical Center Lebanon New Hampshire 03756-0001
Clinical Research Alliance, Inc. Lake Success New York 11042
Durham Va Medical Center (111g) Durham North Carolina 27705
Carolina Biooncology Institute Huntersville North Carolina 28078
Novant Health Oncology Specialists Lexington North Carolina 27295
Gabrail Cancer Center Research Canton Ohio 44718
Oklahoma Oncology And Hematology, Pc Dba Tulsa Oklahoma 74146
Kaiser Permanente Northwest Region Portland Oregon 97227
Guthrie Medical Group, P.C. Sayre Pennsylvania 18840
Wjb Dorn Va Medical Center Columbia South Carolina 29209
Cancer Center Of The Carolinas Greenville South Carolina 29615
Associated in Oncology and Hematology Chattanooga Tennessee 37421
Tennessee Cancer Specialists Knoxville Tennessee 37909
Thompson Oncology Group Knoxville Tennessee 37916
Texas Oncology, PA - South Austin Cancer Center Austin Texas 78745
Blue Ridge Cancer Care Blacksburg Virginia 24060
Wisconsin Institutes for Medical Research Madison Wisconsin 53705

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 257 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01285609, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 17, 2020 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01285609 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →